Show simple item record

dc.contributor.advisorSeese, Cherrien
dc.contributor.advisorO'Connor, J.P.en
dc.contributor.authorStockwell, Jayda Roseen
dc.date.accessioned2026-02-20T23:01:19Z
dc.date.available2026-02-20T23:01:19Z
dc.date.issued2025-05en
dc.identifier.uriarchives.northwestu.edu/handle/nu/86126
dc.descriptionAn undergraduate thesis submitted in partial satisfaction of the requirements for completing the Northwest University Honors Program.en
dc.description.abstractKetamine, initially recognized as an anesthetic, has now gained recognition as a paramount treatment remedy for major depressive disorder and patients with treatment-resistant paramount treatment remedy for major depressive disorder and patients with treatment-resistant for an advanced evidence-based approach to the management of major depressive disorder.en
dc.format.extent21 pagesen
dc.format.mediumDOCXen
dc.language.isoenen
dc.publisherNorthwest Universityen
dc.rightsThis original work is protected by copyright. Copyright is retained by the author(s). Works may be viewed, downloaded, or printed, but not reproduced or distributed without author(s) permission.
dc.rights.urihttp://archives.northwestu.edu/page/copyright
dc.subjectDepression, Mentalen
dc.subjectMedicineen
dc.subjectDepression, Mental—Treatmenten
dc.subjectMajor depressive disorderen
dc.subjectKetamineen
dc.titleWhich is Deadlier: Depression or the Medication? A Research Comparison of Lanicemine and Ketamine for Treatments of Major Depressive Disorderen
thesis.degree.nameSchool of Nursingen
thesis.degree.levelUndergraduateen
thesis.degree.grantorNorthwest Universityen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record